Skip to main content Skip to main navigation menu Skip to site footer

Transcatheter aortic valve implantation: A review article

  • Starry Homenta Rampengan ,
  • Jansen Chitrahadinata ,

Abstract

Aortic stenosis is a valvular heart disease commonly found in developed and developing countries. The frequency of aortic valve sclerosis is about 25% in people over 65 years of age. In contrast to developing countries, infectious diseases, such as endocarditis or rheumatic fever, contribute greatly to aortic stenosis. Severe aortic stenosis without valve replacement has a poor prognosis and some patients are at high risk for surgery. Transcatheter aortic valve implantation (TAVI) is emerging as an alternative in patients with aortic stenosis who cannot or are at high risk for surgery. TAVI has revolutionized the management of aortic stenosis. This procedure continues to improve yearly and exceeds surgical aortic valve replacement in 2019. Initially, TAVI generated skepticism and criticism, but with many clinical trials and evidence-based investigations, TAVI is now widely accepted. Until now, the development of TAVI continues, starting with better technology, approaches, and new implantation strategies; TAVI is becoming safer for patients. This literature review will discuss more deeply about TAVI and its development.

References

  1. Osnabrugge RL, dkk. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. Journal of the American College of Cardiology. 2013;62(1):1002-12.
  2. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(2):920-5.
  3. Coffey S, dkk. The modern epidemiology of heart valve disease. Heart. 2016;102(3):75-85.
  4. Baumgartner H, Walther T. Aortic stenosis. ESC CardioMed: Oxford University Press; 2018. p. 1641-58.
  5. Astor BC, dkk. Mortality after aortic valve replacement: results from a nationally representative database. The Annals of thoracic surgery. 2000;70(5):1939-45.
  6. Iung B, dkk. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. European heart journal. 2003;24(6):1231-43.
  7. Cribier A, dkk. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(7):3006-8.
  8. Grech ED. Practical interventional cardiology: CRC Press; 2017.
  9. Topol EJ, Teirstein PS. Textbook of interventional cardiology E-Book: Elsevier Health Sciences; 2018.
  10. Arsalan M, dkk. TAVI risk scoring using established versus new scoring systems: role of the new STS/ACC model. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2018;13(17):1520-6.
  11. Leon MB, dkk. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Journal of the American College of Cardiology. 2011;57(11):253-69.
  12. Kappetein AP, dkk. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Journal of the American College of Cardiology. 2012;60(12):1438-54.
  13. Young MN, Inglessis I. Transcatheter aortic valve replacement: outcomes, indications, complications, and innovations. Current treatment options in cardiovascular medicine. 2017;19(18):1-17.
  14. Cavalcanti JS, dkk. Morphometric and topographic study of coronary ostia. Arquivos brasileiros de cardiologia. 2003;81(14):359-62.
  15. Piazza N, dkk. Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circulation: Cardiovascular Interventions. 2008;1(15):74-81.
  16. Mukherjee D, dkk. Cardiovascular Catheterization and Intervention: A Textbook of Coronary, second edition. Peripheral, and Structural Heart Disease. 2018(16).
  17. Di Mario C, dkk. The 2011-12 pilot European Sentinel registry of transcatheter Aortic valve implantation: in-hospital results in 4,571 patients. 2013(19).
  18. Edwards FH, dkk. Prediction of operative mortality after valve replacement surgery. Journal of the American College of Cardiology. 2001;37(20):885-92.
  19. Ruggeri L, dkk. Anesthetic management for percutaneous aortic valve implantation: an overview of worldwide experiences. HSR proceedings in intensive care & cardiovascular anesthesia. 2012;4(21):40.
  20. Durand E, dkk. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC: Cardiovascular Interventions. 2012;5(30):461-7.
  21. Sharp AS, dkk. A new technique for vascular access management in transcatheter aortic valve implantation. Catheterization and Cardiovascular Interventions. 2010;75(22):784-93.
  22. Cribier A. The development of transcatheter aortic valve replacement (TAVR). Global cardiology science & practice. 2016;2016(9).
  23. Zaman S, dkk. Pre-transcatheter aortic valve implantation workup in the cardiac catheterisation laboratory. Heart, Lung and Circulation. 2015;24(23):1162-70.
  24. Noble S, Roffi M. Pressure curve measurements during transcatheter aortic valve implantation: a useful tool to assess the severity of aortic regurgitation. The Annals of thoracic surgery. 2013;95(24):e21.
  25. Sinning J-M, dkk. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. Journal of the American College of Cardiology. 2012;59(25):1134-41.
  26. Noble S, dkk. Anatomo-pathological analysis after CoreValve Revalving system implantation. EuroIntervention. 2009;5(26):78-85.
  27. Virmani R, dkk. Accumulation of worldwide experience with postmortem studies of transcatheter aortic valve implantation–what should we be avoiding. Serruys P, Piazza N, Cribier A et al Transcatheter aortic valve implantation: Tips and tricks to avoid failure New York: Informa. 2011(27).
  28. Genereux P, dkk. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC: Cardiovascular Interventions. 2011;4(28):861-7.
  29. Nietlispach F, dkk. Pathology of transcatheter valve therapy. JACC: Cardiovascular Interventions. 2012;5(29):582-90.
  30. Kodali S, dkk. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. European heart journal. 2016;37(32):2252-62.
  31. Vahanian A. 30-day outcomes of intermediate-risk patients with the new-generation balloon-expandable transcatheter heart valve via the transfemoral approach. EuroPCR Paris, France. 2015(33).
  32. Manoharan G, dkk. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC: Cardiovascular Interventions. 2015;8(34):1359-67.
  33. Tchetche D, dkk. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2012;8(35):556-62.
  34. Voigtländer L, dkk. Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis. International journal of cardiology. 2015;178(38):275-81.
  35. Dumonteil N, dkk. Impact of preoperative chronic kidney disease on short-and long-term outcomes after transcatheter aortic valve implantation: a Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC-Plus) initiative substudy. American heart journal. 2013;165(31):752-60.
  36. Zajarias A, dkk. Successful coronary intervention after percutaneous aortic valve replacement. Catheterization and Cardiovascular Interventions. 2007;66(36):522-4.
  37. Webb JG, dkk. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116(37):755-63.
  38. Carroll JD, dkk. STS-ACC TVT registry of transcatheter aortic valve replacement. Journal of the American College of Cardiology. 2020;76(39):2492-516.
  39. Tay ELW, dkk. Management of severe aortic stenosis: the Singapore and Asian perspective. Singapore medical journal. 2018;59(10):452.
  40. Giannini F, dkk. Transcatheter valve replacement in Asia Pacific: current practice and perspectives. Journal of the American College of Cardiology. 2018(40):3189-99.
  41. Sawa Y, dkk. Clinical efficacy of transcatheter aortic valve replacement for severe aortic stenosis in high-risk patients: the PREVAIL JAPAN trial. Surgery today. 2015(41):34-43.
  42. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin III JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021 Feb 2;77(4):450-500.
  43. Ten Berg J, Sibbing D, Rocca B, Van Belle E, Chevalier B, Collet JP, Dudek D, Gilard M, Gorog DA, Grapsa J, Grove EL. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease. European heart journal. 2021 Jun 14;42(23):2265-9.
  44. Nijenhuis VJ, Brouwer J, Delewi R, Hermanides RS, Holvoet W, Dubois CL, Frambach P, De Bruyne B, van Houwelingen GK, Van Der Heyden JA, Toušek P. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. New England Journal of Medicine. 2020 Apr 30;382(18):1696-707.

How to Cite

Rampengan, S. H., & Jansen Chitrahadinata. (2022). Transcatheter aortic valve implantation: A review article. Bali Medical Journal, 11(3), 1042–1048. https://doi.org/10.15562/bmj.v11i3.3571

HTML
2

Total
3

Share

Search Panel

Starry Homenta Rampengan
Google Scholar
Pubmed
BMJ Journal


Jansen Chitrahadinata
Google Scholar
Pubmed
BMJ Journal